Logo image of HCC

WARRIOR MET COAL INC (HCC) Stock Fundamental Analysis

NYSE:HCC - US93627C1018 - Common Stock

58.97 USD
-0.51 (-0.86%)
Last: 8/27/2025, 8:04:00 PM
58.97 USD
0 (0%)
After Hours: 8/27/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HCC. HCC was compared to 155 industry peers in the Metals & Mining industry. While HCC has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, HCC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

HCC had positive earnings in the past year.
In the past year HCC had a positive cash flow from operations.
HCC had positive earnings in 4 of the past 5 years.
In the past 5 years HCC always reported a positive cash flow from operatings.
HCC Yearly Net Income VS EBIT VS OCF VS FCFHCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.52%, HCC is in the better half of the industry, outperforming 63.23% of the companies in the same industry.
The Return On Equity of HCC (1.94%) is better than 61.29% of its industry peers.
HCC has a Return On Invested Capital of 0.91%. This is comparable to the rest of the industry: HCC outperforms 49.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HCC is significantly above the industry average of 12.86%.
The last Return On Invested Capital (0.91%) for HCC is well below the 3 year average (23.37%), which needs to be investigated, but indicates that HCC had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.52%
ROE 1.94%
ROIC 0.91%
ROA(3y)20.53%
ROA(5y)13.87%
ROE(3y)27.27%
ROE(5y)18.84%
ROIC(3y)23.37%
ROIC(5y)N/A
HCC Yearly ROA, ROE, ROICHCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

The Profit Margin of HCC (3.30%) is better than 65.81% of its industry peers.
In the last couple of years the Profit Margin of HCC has declined.
HCC's Operating Margin of 2.08% is in line compared to the rest of the industry. HCC outperforms 50.97% of its industry peers.
HCC's Operating Margin has declined in the last couple of years.
The Gross Margin of HCC (20.38%) is better than 60.65% of its industry peers.
HCC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.08%
PM (TTM) 3.3%
GM 20.38%
OM growth 3Y-15.98%
OM growth 5Y-11.14%
PM growth 3Y4.87%
PM growth 5Y-7.13%
GM growth 3Y-11.66%
GM growth 5Y-5.37%
HCC Yearly Profit, Operating, Gross MarginsHCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HCC is creating value.
The number of shares outstanding for HCC has been increased compared to 1 year ago.
Compared to 5 years ago, HCC has less shares outstanding
Compared to 1 year ago, HCC has an improved debt to assets ratio.
HCC Yearly Shares OutstandingHCC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HCC Yearly Total Debt VS Total AssetsHCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

HCC has an Altman-Z score of 5.09. This indicates that HCC is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.09, HCC is in the better half of the industry, outperforming 72.26% of the companies in the same industry.
HCC has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
HCC has a better Debt to Equity ratio (0.10) than 60.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 5.09
ROIC/WACC0.09
WACC10.1%
HCC Yearly LT Debt VS Equity VS FCFHCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 4.59 indicates that HCC has no problem at all paying its short term obligations.
The Current ratio of HCC (4.59) is better than 80.65% of its industry peers.
HCC has a Quick Ratio of 3.44. This indicates that HCC is financially healthy and has no problem in meeting its short term obligations.
HCC has a Quick ratio of 3.44. This is in the better half of the industry: HCC outperforms 72.90% of its industry peers.
Industry RankSector Rank
Current Ratio 4.59
Quick Ratio 3.44
HCC Yearly Current Assets VS Current LiabilitesHCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

HCC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.18%.
The Earnings Per Share has been decreasing by -2.09% on average over the past years.
HCC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.54%.
HCC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.76% yearly.
EPS 1Y (TTM)-89.18%
EPS 3Y5.15%
EPS 5Y-2.09%
EPS Q2Q%-91.85%
Revenue 1Y (TTM)-27.54%
Revenue growth 3Y12.92%
Revenue growth 5Y3.76%
Sales Q2Q%-24.97%

3.2 Future

The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.17% on average over the next years. This is quite good.
EPS Next Y-98.36%
EPS Next 2Y-2.11%
EPS Next 3Y12.68%
EPS Next 5YN/A
Revenue Next Year-18.53%
Revenue Next 2Y7.47%
Revenue Next 3Y9.67%
Revenue Next 5Y8.17%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HCC Yearly Revenue VS EstimatesHCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
HCC Yearly EPS VS EstimatesHCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 65.52, the valuation of HCC can be described as expensive.
HCC's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.14. HCC is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 12.48, which indicates a correct valuation of HCC.
HCC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HCC is cheaper than 71.61% of the companies in the same industry.
HCC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 65.52
Fwd PE 12.48
HCC Price Earnings VS Forward Price EarningsHCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

HCC's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.19
HCC Per share dataHCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The decent profitability rating of HCC may justify a higher PE ratio.
HCC's earnings are expected to grow with 12.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.11%
EPS Next 3Y12.68%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.56%, HCC is not a good candidate for dividend investing.
HCC's Dividend Yield is a higher than the industry average which is at 2.59.
Compared to an average S&P500 Dividend Yield of 2.34, HCC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.56%

5.2 History

The dividend of HCC decreases each year by -28.78%.
HCC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-28.78%
Div Incr Years0
Div Non Decr Years0
HCC Yearly Dividends per shareHCC Yearly Dividends per shareYearly Dividends per share 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

HCC pays out 42.14% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP42.14%
EPS Next 2Y-2.11%
EPS Next 3Y12.68%
HCC Yearly Income VS Free CF VS DividendHCC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
HCC Dividend Payout.HCC Dividend Payout, showing the Payout Ratio.HCC Dividend Payout.PayoutRetained Earnings

WARRIOR MET COAL INC

NYSE:HCC (8/27/2025, 8:04:00 PM)

After market: 58.97 0 (0%)

58.97

-0.51 (-0.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners112.84%
Inst Owner Change3.69%
Ins Owners2.05%
Ins Owner Change0.77%
Market Cap3.10B
Analysts78
Price Target66.98 (13.58%)
Short Float %15.22%
Short Ratio6.77
Dividend
Industry RankSector Rank
Dividend Yield 0.56%
Yearly Dividend0.84
Dividend Growth(5Y)-28.78%
DP42.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-08 2025-08-08 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1569.91%
Min EPS beat(2)-3268.32%
Max EPS beat(2)128.5%
EPS beat(4)2
Avg EPS beat(4)-796.46%
Min EPS beat(4)-3268.32%
Max EPS beat(4)128.5%
EPS beat(8)4
Avg EPS beat(8)-395.03%
EPS beat(12)6
Avg EPS beat(12)-261.72%
EPS beat(16)8
Avg EPS beat(16)-194.33%
Revenue beat(2)2
Avg Revenue beat(2)1.8%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)2.62%
Revenue beat(8)6
Avg Revenue beat(8)1.64%
Revenue beat(12)8
Avg Revenue beat(12)0.7%
Revenue beat(16)11
Avg Revenue beat(16)3.04%
PT rev (1m)6.78%
PT rev (3m)0.72%
EPS NQ rev (1m)-98.34%
EPS NQ rev (3m)-99.05%
EPS NY rev (1m)-89.64%
EPS NY rev (3m)-92.77%
Revenue NQ rev (1m)-6.06%
Revenue NQ rev (3m)-24.85%
Revenue NY rev (1m)-4.39%
Revenue NY rev (3m)-5.26%
Valuation
Industry RankSector Rank
PE 65.52
Fwd PE 12.48
P/S 2.54
P/FCF N/A
P/OCF 18.8
P/B 1.49
P/tB 1.49
EV/EBITDA 15.19
EPS(TTM)0.9
EY1.53%
EPS(NY)4.72
Fwd EY8.01%
FCF(TTM)-5.21
FCFYN/A
OCF(TTM)3.14
OCFY5.32%
SpS23.26
BVpS39.57
TBVpS39.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.52%
ROE 1.94%
ROCE 1.04%
ROIC 0.91%
ROICexc 1.1%
ROICexgc 1.1%
OM 2.08%
PM (TTM) 3.3%
GM 20.38%
FCFM N/A
ROA(3y)20.53%
ROA(5y)13.87%
ROE(3y)27.27%
ROE(5y)18.84%
ROIC(3y)23.37%
ROIC(5y)N/A
ROICexc(3y)38.43%
ROICexc(5y)N/A
ROICexgc(3y)38.43%
ROICexgc(5y)N/A
ROCE(3y)26.69%
ROCE(5y)N/A
ROICexcg growth 3Y-25.32%
ROICexcg growth 5Y-18.92%
ROICexc growth 3Y-25.32%
ROICexc growth 5Y-18.92%
OM growth 3Y-15.98%
OM growth 5Y-11.14%
PM growth 3Y4.87%
PM growth 5Y-7.13%
GM growth 3Y-11.66%
GM growth 5Y-5.37%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 1.11
Cap/Depr 266.87%
Cap/Sales 35.87%
Interest Coverage 250
Cash Conversion 86.87%
Profit Quality N/A
Current Ratio 4.59
Quick Ratio 3.44
Altman-Z 5.09
F-Score3
WACC10.1%
ROIC/WACC0.09
Cap/Depr(3y)316.54%
Cap/Depr(5y)219.43%
Cap/Sales(3y)25.98%
Cap/Sales(5y)19.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.18%
EPS 3Y5.15%
EPS 5Y-2.09%
EPS Q2Q%-91.85%
EPS Next Y-98.36%
EPS Next 2Y-2.11%
EPS Next 3Y12.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-27.54%
Revenue growth 3Y12.92%
Revenue growth 5Y3.76%
Sales Q2Q%-24.97%
Revenue Next Year-18.53%
Revenue Next 2Y7.47%
Revenue Next 3Y9.67%
Revenue Next 5Y8.17%
EBIT growth 1Y-94.49%
EBIT growth 3Y-5.12%
EBIT growth 5Y-7.8%
EBIT Next Year-29.69%
EBIT Next 3Y34.29%
EBIT Next 5Y28.18%
FCF growth 1Y-172.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.29%
OCF growth 3Y1.49%
OCF growth 5Y-7.16%